{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:30:21Z","timestamp":1788561021050,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 20K16468"],"award-info":[{"award-number":["JP 20K16468"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T11:46:36Z","timestamp":1639223196000},"page":"432-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of BCG vaccine in animal models of neurological disorders"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0557-9467","authenticated-orcid":false,"given":"Davide","family":"Cossu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-999X","authenticated-orcid":false,"given":"Stefano","family":"Ruberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-1093","authenticated-orcid":false,"given":"Kazumasa","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcp.2013.06.016","article-title":"Animal models of CNS disorders","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0010","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.3389\/fmicb.2018.02966","article-title":"Bacteria-Host Interactions in Multiple Sclerosis","volume":"9","author":"Cossu","year":"2018","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.12.005_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092109","article-title":"Lessons from Bacillus Calmette-Guerin: Harnessing Trained Immunity for Vaccine Development","volume":"9","author":"Pasco","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2021.12.005_b0020","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design","volume":"10","author":"Covian","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0025","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3389\/fimmu.2018.02869","article-title":"Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations","volume":"9","author":"Uthayakumar","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.12.005_b0030","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1172\/JCI133935","article-title":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2021.12.005_b0035","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","article-title":"Neuroinflammation as a Common Feature of Neurodegenerative Disorders","volume":"10","author":"Guzman-Martinez","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fneur.2017.00216","article-title":"Conflicting Role of Mycobacterium Species in Multiple Sclerosis","volume":"8","author":"Cossu","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2021.12.005_b0050","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.005_b0055","doi-asserted-by":"crossref","first-page":"104069","DOI":"10.1016\/j.lpm.2021.104069","article-title":"Pediatric Onset Multiple sclerosis: future challenge for early diagnosis and treatment","volume":"50","author":"de Chalus","year":"2021","journal-title":"Presse Med"},{"issue":"8","key":"10.1016\/j.vaccine.2021.12.005_b0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and Treatment of Multiple Sclerosis: A Review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2021.12.005_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2018.09.016","article-title":"Bridging the gap between vaccination with Bacille Calmette-Guerin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis","volume":"55","author":"Ristori","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.005_b0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00415-003-0967-6","article-title":"The effect of Bacille Calmette-Guerin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS","volume":"250","author":"Paolillo","year":"2003","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","article-title":"Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS","volume":"82","author":"Ristori","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03370-z","article-title":"Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system","volume":"7","author":"Cossu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.12.005_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577694","article-title":"PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE)","volume":"359","author":"Cossu","year":"2021","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.12.005_b0090","first-page":"564","article-title":"Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis","volume":"10","author":"Sewell","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.12.005_b0095","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.4049\/jimmunol.181.9.6201","article-title":"Mycobacterium bovis bacille Calmette-Guerin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner","volume":"181","author":"Lee","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.005_b0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/08923973.2021.1878215","article-title":"Mycobacterium bovis BCG-mediated suppression of Th17 response in mouse experimental autoimmune encephalomyelitis","volume":"43","author":"Matsuzaki","year":"2021","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0105","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3389\/fimmu.2018.02777","article-title":"Extended Freeze-Dried BCG Instructed pDCs Induce Suppressive Tregs and Dampen EAE","volume":"9","author":"Lippens","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/721383","article-title":"BCG and BCG\/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis","volume":"2013","author":"Zorzella-Pezavento","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.005_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2005.01.005","article-title":"Infection-induced apoptosis deletes bystander CD4+ T cells: a mechanism for suppression of autoimmunity during BCG infection","volume":"24","author":"O'Connor","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2021.12.005_b0120","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-210462","article-title":"Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease","author":"Handy","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.vaccine.2021.12.005_b0130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2016.09.007","article-title":"Abeta vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Abeta, and microhemorrhages","volume":"49","author":"Davis","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.vaccine.2021.12.005_b0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.vaccine.2021.12.005_b0140","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4161\/hv.24830","article-title":"Immunotherapeutic efficiency of a tetravalent Abeta1-15 vaccine in APP\/PS1 transgenic mice as mouse model for Alzheimer's disease","volume":"9","author":"Guan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.12.005_b0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2017.02.001","article-title":"Immunization with Bacillus Calmette-Guerin (BCG) alleviates neuroinflammation and cognitive deficits in APP\/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain","volume":"101","author":"Zuo","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.005_b0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.vaccine.2021.12.005_b0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2021.01.001","article-title":"Bacille Calmette-Guerin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP\/PS1 mice following active amyloid-beta immunotherapy","volume":"101","author":"Zuo","year":"2021","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.vaccine.2021.12.005_b0160","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2021.12.005_b0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mehy.2019.01.007","article-title":"Can immunization with Bacillus Calmette-Guerin (BCG) protect against Alzheimer's disease?","volume":"123","author":"Gofrit","year":"2019","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.vaccine.2021.12.005_b0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2018.00029","article-title":"Adjuvant Effect of Bacille Calmette-Guerin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn","volume":"9","author":"Scheid","year":"2018","journal-title":"Front Immunol"},{"issue":"10291","key":"10.1016\/j.vaccine.2021.12.005_b0175","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.005_b0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fncel.2018.00247","article-title":"Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson's disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J Parkinsons Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2021.12.005_b0195","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.3390\/ijms20215312","article-title":"The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease","volume":"20","author":"Lin","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.005_b0200","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2021.12.005_b0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0210","doi-asserted-by":"crossref","first-page":"e16610","DOI":"10.1371\/journal.pone.0016610","article-title":"BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease","volume":"6","author":"Yong","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2021.12.005_b0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000071472","article-title":"Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes","volume":"10","author":"Banks","year":"2002","journal-title":"NeuroImmunoModulation"},{"issue":"6","key":"10.1016\/j.vaccine.2021.12.005_b0220","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.vaccine.2009.11.004","article-title":"Complex cytokine profiles induced by BCG vaccination in UK infants","volume":"28","author":"Lalor","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.005_b0225","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","article-title":"Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection","volume":"177","author":"Cruz","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.12.005_b0230","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jnr.23253","article-title":"Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"91","author":"Lacan","year":"2013","journal-title":"J Neurosci Res"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.005_b0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/iju.13538","article-title":"Bacillus Calmette-Guerin strain differences as the basis for immunotherapies against bladder cancer","volume":"25","author":"Miyazaki","year":"2018","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0240","first-page":"4","article-title":"Overview of Neurocognitive Disorders","volume":"15","author":"McDonald","year":"2017","journal-title":"Focus (Am Psychiatr Publ)"},{"issue":"01","key":"10.1016\/j.vaccine.2021.12.005_b0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.13r08710","article-title":"Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice","volume":"75","author":"Papakostas","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ejn.14720","article-title":"Neuroinflammation and depression: A review","volume":"53","author":"Troubat","year":"2021","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.005_b0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.30773\/pi.2019.0234","article-title":"Protective Effect of Sphaerococcus coronopifolius Crude Extract in Combination with Bacillus Calmette-Guerin on Ligature-Induced Depression in Female Wistar Rats","volume":"17","author":"Fellah","year":"2020","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.vaccine.2021.12.005_b0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainresbull.2015.10.012","article-title":"Neonatal BCG vaccination of mice improves neurogenesis and behavior in early life","volume":"120","author":"Yang","year":"2016","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0265","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/21645515.2015.1056954","article-title":"Neonatal vaccination with bacille Calmette-Guerin promotes the dendritic development of hippocampal neurons","volume":"12","author":"Li","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.005_b0270","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0808-7","article-title":"Combined effect of BCG vaccination and enriched environment promote neurogenesis and spatial cognition via a shift in meningeal macrophage M2 polarization","volume":"14","author":"Qi","year":"2017","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.vaccine.2021.12.005_b0275","doi-asserted-by":"crossref","first-page":"e0225874","DOI":"10.1371\/journal.pone.0225874","article-title":"The adoptive transfer of BCG-induced T lymphocytes contributes to hippocampal cell proliferation and tempers anxiety-like behavior in immune deficient mice","volume":"15","author":"Song","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.12.005_b0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbi.2014.06.205","article-title":"Bacillus Calmette-Guerin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice","volume":"42","author":"Vijaya Kumar","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.005_b0285","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/JLB.5MA0118-027R","article-title":"The impact of sex hormones on BCG-induced trained immunity","volume":"104","author":"de Bree","year":"2018","journal-title":"J Leukoc Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:05:15Z","timestamp":1759403115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21016133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21016133"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of BCG vaccine in animal models of neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}